I agree that this site is using cookies. You can find further informations here.
X
Bokemeyer, B
259  results:
Search for persons X
?
1

P683 Economic impact of achieving mucosal healing on UC-rel..:

Peyrin-Biroulet, L ; Ungaro, R ; Rubin, D T...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1298-i1299 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P792 Real-world evidence comparison of the effectiveness of..:

Bokemeyer, B ; Plachta-Danielzik, S ; Howaldt, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1480-i1481 , 2024
Link: https://doi.org/10.1093/..
 
?
3

N02 Inflammatory bowel disease patients with impaired quali..:

Hartmann, P ; Zemke, J ; Plachta-Danielzik, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i2199-i2200 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P784 Real-world use and 6-month effectiveness of vedolizuma..:

Plachta-Danielzik, S ; Bokemeyer, B ; Efken, P...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i918-i919 , 2023
Link: https://doi.org/10.1093/..
 
?
5

P742 Real-world evidence comparison on the effectiveness of..:

Bokemeyer, B ; Plachta-Danielzek, S ; Howaldt, S...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i872-i873 , 2023
Link: https://doi.org/10.1093/..
 
?
6

RWD113 Switching to TNFi Versus Non-TNFi Biologics in Ulcer..:

Zhuleku, E. ; Wirth, D. ; Nissinen, R....
Value in Health.  26 (2023)  12 - p. S525-S526 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P801 Maintenance phase effectiveness and persistence after ..:

Plachta-Danielzik, S ; Bokemeyer, B ; Efken, P...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i933-i934 , 2023
Link: https://doi.org/10.1093/..
 
?
8

OP36 Real-world evidence on comparative effectiveness of Us..:

Bokemeyer, B ; Plachta-Danielzik, S ; Deppe, H...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i50-i50 , 2023
Link: https://doi.org/10.1093/..
 
?
9

P414 Comparative real-world effectiveness and persistence o..:

Bokemeyer, B ; Plachta-Danielzik, S ; Efken, P...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i543-i544 , 2023
Link: https://doi.org/10.1093/..
 
?
10

DOP77 Comparative real-world effectiveness and persistence ..:

Di Giuseppe, R ; Plachta-Danielzik, S ; Bokemeyer, B...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i120-i121 , 2022
Link: https://doi.org/10.1093/..
 
?
11

DOP47 Identification and characterization of T-cell recepto..:

Pesesky, M ; Carty, C L ; Singh, N...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i096-i097 , 2022
Link: https://doi.org/10.1093/..
 
?
12

OP17 Maintenance phase propensity score adjusted effectiven..:

Plachta-Danielzik, S ; di Giuseppe, R ; Bokemeyer, B...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i018-i019 , 2022
Link: https://doi.org/10.1093/..
 
?
13

P506 Rates of clinical remission among patients with Ulcera..:

Bokemeyer, B ; Picker, N ; Kromer, D..
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i466-i467 , 2022
Link: https://doi.org/10.1093/..
 
?
14

P598 Indicators for inadequate response among patients with..:

Bokemeyer, B ; Picker, N ; Kromer, D..
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i532-i533 , 2022
Link: https://doi.org/10.1093/..
 
?
15

P601 Real World Evidence on the comparative effectiveness o..:

Bokemeyer, B ; Plachta-Danielzik, S ; di Giuseppe, R...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i534-i535 , 2022
Link: https://doi.org/10.1093/..
 
1-15